The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024.
The post AMA: PBM Market Concentration Is On the Rise appeared first on MedCity News.
AMA: PBM Market Concentration Is On the Rise
